Top compounds associated with response to OR4D5


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.003
mRNA TL-2-105 GDSC1000 pan-cancer AAC 0.095 0.003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.003
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.1 0.003
mRNA HG-5-113-01 GDSC1000 pan-cancer AAC 0.13 0.004
mRNA avrainvillamide CTRPv2 pan-cancer AAC 0.12 0.004
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC 0.15 0.004
mRNA JW-7-52-1 GDSC1000 pan-cancer AAC -0.14 0.005
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.098 0.005
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.005
Download CSV